Cargando…
COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation
Complications resulting from coronavirus disease 2019 (COVID-19) sequelae have been well documented. These include blood conditions such as lymphopenia, thrombocytopenia, and hypercoagulability. Less common problems that may arise are disseminated intravascular coagulation (DIC), immune thrombocytop...
Autores principales: | Dube, Michael D, Sapkota, Sumina, Lakhatariya, Khushboo, Russo, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867565/ https://www.ncbi.nlm.nih.gov/pubmed/36694508 http://dx.doi.org/10.7759/cureus.32845 |
Ejemplares similares
-
Purpura Fulminans: A Cutaneous Marker of Disseminated Intravascular Coagulation
por: Ghosh, Sudip Kumar, et al.
Publicado: (2009) -
Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
por: Gorchynski, Julie, et al.
Publicado: (2008) -
Hydralazine-Induced Lupus Presenting With Pancytopenia: A Case Report
por: Brar, Yudhveer, et al.
Publicado: (2022) -
Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014) -
Coagulation Inhibitors in COVID-19 Leading to Compressive Airway Hematoma
por: Mohamed, Amr
Publicado: (2021)